Phase I/II Study of Decitabine (DAC) Followed by Clofarabine, Idarubicin, and Cytarabine (CIA) in Acute Leukemia
Phase of Trial: Phase I/II
Latest Information Update: 23 Jan 2018
At a glance
- Drugs Clofarabine (Primary) ; Cytarabine; Decitabine; Idarubicin
- Indications Acute myeloid leukaemia
- Focus Adverse reactions
- 17 Jan 2018 Status changed from active, no longer recruiting to completed.
- 19 May 2017 Status changed from recruiting to active, no longer recruiting.
- 06 Dec 2016 Interim results (n=54) presented at the 58th Annual Meeting and Exposition of the American Society of Hematology.